Supplementary Materials

Supplementary Material for:

Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis

Jonathan J. Miner, Lindsey E. Cook, Jun P. Hong, Amber M. Smith, Justin M. Richner, Raeann M. Shimak, Alissa R. Young, Kristen Monte, Subhajit Poddar, James E. Crowe Jr., Deborah J. Lenschow,* Michael S. Diamond*

*Corresponding author. Email: diamond{at}borcim.wustl.edu (M.S.D.); dlenschow{at}wustl.edu (D.J.L.)

Published 1 February 2017, Sci. Transl. Med. 9, eaah3438 (2017)
DOI: 10.1126/scitranslmed.aah3438

This PDF file includes:

  • Fig. S1. RANKL and OPG expression in CHIKV-infected joints.
  • Fig. S2. Foot swelling with CTLA4-Ig therapy administered before or during CHIKV infection.
  • Fig. S3. Flow cytometry analysis of APC activation in the spleen and ankles of mice on day 7 after infection with CHIKV.

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Table S1 (Microsoft Excel format). Primary data.